Cite

    Bose, A. et al. (2016). A randomized non-inferiority clinical study to assess post-exposure prophylaxis by a new purified vero cell rabies vaccine (Rabivax-S) administered by intramuscular and intradermal routes. Vaccine. 34 (40), pp. 4820-4826. [Online].